The largest database of trusted experimental protocols

4 protocols using anti o glcnac ctd110.6

1

Immunoblot Analysis of O-GlcNAc Modification

Check if the same lab product or an alternative is used in the 5 most similar protocols
IP and immunobloting experiments were performed as previously described (42 (link)). O-GlcNAc was enriched by treating the cells with Glu plus TMG as previously described (treated with 5 μM TMG for 24 h and 30 mM Glu for 3 h) (41 (link)). Antibodies used were as follows: anti-ULK1 (CST; catalog no.: 8054), anti-OGT (Santa Cruz; catalog no.: sc-32921), anti-O-GlcNAc (RL2) (Abcam; catalog no.: ab2739), anti-O-GlcNAc (CTD110.6) (Sigma; catalog no.: O7764), LC3B (CST; catalog no.: 2775S), and anti-STX17 (Merck; catalog no.: HPA001204).
Peroxidase-conjugated secondary antibodies were from Jackson ImmunoResearch. Blotted proteins were visualized using the ECL detection system (Amersham). Signals were detected by a LAS-4000 (Fujifilm) and quantitatively analyzed by densitometry using the Multi Gauge software (Fujifilm). All Western blots were repeated at least three times. Silver staining analysis was performed as described (41 (link)).
+ Open protocol
+ Expand
2

Western Blot Analysis of O-GlcNAc Modifications

Check if the same lab product or an alternative is used in the 5 most similar protocols
Proteins were run on 12% SDS-PAGE under reducing conditions. Gels were either stained with Coomassie blue or electroblotted onto a PVDF sheet. Blots were saturated with 5% (w/v) blotting-grade blocker (Bio-Rad) in TBS (Tris-buffered saline)-Tween [15 mM Tris, 140 mM NaCl, 0.5% (v/v) Tween] for 30 min. Primary antibodies were incubated overnight at 4°C. Mouse monoclonal anti-O-GlcNAc RL2 (ab2739) was used at a 1:1,000 dilution; mouse polyclonal anti-O-GlcNAc CTD 110.6 and anti-alpha tubulin DM1A (Sigma, St Louis Missouri, USA) antibodies were also used. The specificity of the RL2 antibodies was checked by co-incubation with 1 M free O-GlcNAc. Then, the membranes were washed three times for 10 min with TBS-Tween and incubated with anti-mouse IgG or IgM, HRP labeled secondary antibodies (Abcam, Cambridge, UK) at a 1:5,000 dilution. The membranes were washed three times for 10 min with TBS-Tween, and spots were detected by enhanced chemiluminescence with Hyperfilms (GE Healthcare, Chicago, USA). Three independent experiments were performed and images were captured using a Bio Rad Gel Doc imaging system and processed with Quantity One software. One representative blot is shown.
+ Open protocol
+ Expand
3

Protein Extraction and Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were collected in RIPA lysis buffer (150mM NaCl, 1% NP40, 0.5% DOC, 50mM Tris-HCl at pH 8, 0.1% SDS, 10% glycerol, 5mM EDTA, 20mM NaF and 1mM Na3VO4, 1 μg/ml each of pepstatin, leupeptin, and aprotinin, 200 μg/ml phenyl-methylsulfonyl-fluoride). Lysates were cleared by centrifugation at 14,000 x g for 20 minutes at 4 °C and analyzed by SDS-PAGE and autoradiography. Western blots were then analyzed with the following antibodies; anti-Actin, anti-c-MYC, anti-ERK2 (D-2), anti-O-GlcNAc (RL2), anti-Cyclin D1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-phospho-Akt (Ser473), anti-phospho-Akt (T308), anti- P70 S6 Kinase, anti-Tuberin/TSC2, anti-AKT, anti-phospho-P70-S6 Kinase (T389) and anti-phospho-4EBP1 (T70), anti-4EBP1 (53H17), Cleaved Caspase 3 (D175), anti-BIM, anti-CHOP (L63F7), anti-phospho-eIF2α, anti-eIF2α (Cell Signaling, Danvers, MA, USA), anti-phospho-ERK (T185/Y187) (Invitrogen Corporation, Carlsbad, CA, USA), anti-OGT, anti-O-GlcNAc (CTD110.6) (Sigma, St Louis, MO, USA), anti-HSP90 alpha (Enzo Life Sciences, Farmingdale, NY, USA) and anti-MGEA5 (OGA) (Proteintech Group, Chicago, IL, USA). Densitometry was performed using Image J Software (National Institutes of Health, Bethesda, MA).
+ Open protocol
+ Expand
4

Antibody Sourcing for Biochemical Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies were purchased as follows: anti-GST 1-109 (sc-33613), anti-OGT (sc-32921), anti-CK2α (sc-12738), and anti-Nup62 (sc-48373) from Santa Cruz Biotechnology; anti-O-GlcNAc RL2 from Abcam; anti-T7 and anti-S tags from Novagen.; anti-Flag (F1804), anti-Actin, anti-O-GlcNAc (CTD110.6), and anti-His (H1029) from Sigma-Aldrich; and anti-HA (3F10) from Roche Applied Science.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!